Velcade and malignant neoplasm progression Patient Reports February 11, 2012

Velcade Side Effects Report #5366205-0
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, IV BOLUS. Patient died.

Velcade Side Effects Report #5366206-2
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5366207-4
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5366219-0
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.


Velcade Side Effects Report #5368528-8
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, IV BOLUS. Patient died.

Velcade Side Effects Report #5369637-X
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5369638-1
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5369639-3
Velcade side effect was reported by a Physician from UNITED STATES on June 07, 2007. Female patient was diagnosed with transitional cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient died.

Velcade Side Effects Report #5140627-5
Velcade side effect was reported by a Physician from FRANCE on Oct 18, 2006. Female patient, 56 years of age, weighting 114.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , escherichia infection, lymphoma , malignant neoplasm progression. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXIL, VINDESINE, BLEOMYCIN, LENOGRASTIM, METHOTREXATE. Patient was hospitalized. Patient died on 10/10/2006.


Velcade Side Effects Report #5145389-3
Velcade side effect was reported by a Physician from FRANCE on Oct 24, 2006. Female patient, 56 years of age, weighting 114.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, culture stool positive, cytomegalovirus infection , escherichia infection, lymphoma , malignant neoplasm progression. Velcade dosage: 2.30 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXIL, VINDESINE, BLEOMYCIN, LENOGRASTIM, METHOTREXATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5129980-6
Velcade side effect was reported by a Physician from GERMANY on Sept 05, 2006. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, plasmacytoma. Velcade dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient died on 05/27/2006.

Velcade Side Effects Report #5080830-6
Velcade side effect was reported by a Physician from GERMANY on Aug 05, 2005. Female patient, 69 years of age, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: bundle branch block right, chest pain , haemoglobin decreased, malignant neoplasm progression, multiple myeloma , myocardial infarction, osteolysis, tachycardia. Velcade dosage: unknown. During the same period patient was treated with PANTOZOL, NOVALGIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4607676-4
Velcade side effect was reported by a Physician from on Mar 01, 2005. Female patient, 50 years of age, weighting 253.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood lactate dehydrogenase increased, cranial nerve palsies multiple, diplopia, headache , malignant neoplasm progression, multiple myeloma , proteinuria. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.

Velcade Side Effects Report #5385943-7
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 29, 2007. Male patient, child 11 years of age, weighting 68.34 lb, was diagnosed with non-renal cell carcinoma of kidney and was treated with Velcade. After drug was administered, patient experienced the following side effects: lung cancer metastatic, malignant neoplasm progression, off label use. Velcade dosage: 1.20 MG/M2, INTRAVENOUS. Patient died on 06/28/2007.


Velcade Side Effects Report #4903630-3
Velcade side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, beta 2 microglobulin increased, blood glucose increased, cholelithiasis, herpes zoster disseminated, inflammation, malignant neoplasm progression, non-hodgkin's lymphoma, platelet count decreased. Velcade dosage: 3.20 MG. During the same period patient was treated with SYNTHROID, AVAPRO, LORAZEPAM, VANCOMYCIN, FLAGYL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5843039-1
Velcade side effect was reported by a Physician from SWITZERLAND on July 29, 2008. Female patient, 89 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , renal failure. Velcade dosage: 1.3 MG/M2 UNK UNK. During the same period patient was treated with DEXAMETHASONE. Patient died on 07/09/2007.

Velcade Side Effects Report #5387450-4
Velcade side effect was reported by a Physician from JAPAN on July 02, 2007. Female patient, 83 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, hyponatraemia, liver disorder, malignant neoplasm progression, multiple myeloma , nerve injury, neuropathy peripheral, platelet count decreased, pleural effusion. Velcade dosage: unknown. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient died on 05/27/2007.

Velcade Side Effects Report #5569873-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacteraemia, malignant neoplasm progression, multiple myeloma , neutropenia, sepsis , thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with REVLIMID. Patient died on 06/26/2007.

Velcade Side Effects Report #5324056-7
Velcade side effect was reported by a Physician from FRANCE on Apr 25, 2007. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.20 MG, INTRAVENOUS. Patient died.


Velcade Side Effects Report #5551274-5
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, haemoglobin decreased, malignant neoplasm progression, multiple myeloma , platelet count decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, BAKTAR, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #5909044-1
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 26, 2008. Male patient, 79 years of age, weighting 189.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient was hospitalized. Patient died on 08/11/2008.

Velcade Side Effects Report #5927317-3
Velcade side effect was reported by a Consumer or non-health professional from NETHERLANDS on Oct 08, 2008. Male patient, 79 years of age, weighting 189.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient was hospitalized. Patient died on 08/11/2008.

Velcade Side Effects Report #5584730-4
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, malignant neoplasm progression, multiple myeloma , nausea , oedema, platelet count decreased, pulmonary oedema, pyrexia. Velcade dosage: 1.90 MG, 1.70 MG , 1.30 MG, 1.90 MG INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.

Velcade Side Effects Report #5584730-4
Velcade side effect was reported by a Physician from JAPAN on Dec 20, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, diarrhoea, malignant neoplasm progression, nausea , oedema, platelet count decreased, pulmonary oedema, pyrexia, white blood cell count decreased. Velcade dosage: 1.90 MG, 1.70 MG , 1.30 MG, 1.90 MG INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.


Velcade Side Effects Report #6049546-3
Velcade side effect was reported by a Consumer or non-health professional from CANADA on Jan 15, 2009. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma , neuropathy peripheral, oedema peripheral, somnolence. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, OXYCODONE, CELEXA, ZOPICLONE, MELPHALAN. Patient died on 03/22/2008.

Velcade Side Effects Report #5483857-5
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 04, 2007. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.79 MG. Patient was hospitalized. Patient died on 09/29/2007.

Velcade Side Effects Report #5741393-2
Velcade side effect was reported by a Physician from FRANCE on May 02, 2008. Male patient, 76 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood viscosity increased, confusional state, hypercalcaemia, malignant neoplasm progression, multiple myeloma , protein total increased. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, LASIX, ODRIK, VASTAC, DIANTALVIC, DIALGIREX, BONIVA. Patient was hospitalized. Patient died on 04/18/2008.

Velcade Side Effects Report #4764789-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2003. Female patient, 76 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, confusional state, delirium, hallucinations, mixed, herpes zoster, malignant neoplasm progression, multiple myeloma , speech disorder. Velcade dosage: 2MG BIW, IV BOLUS. During the same period patient was treated with EFFEXOR, SPIRONOLACTONE, SYNTHROID, METHADONE, NEURONTIN. Patient died on 10/01/2003.

Velcade Side Effects Report #4833523-1
Velcade side effect was reported by a Physician from GERMANY on Nov 02, 2005. Female patient, 76 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, dehydration, malignant neoplasm progression, plasmacytoma. Velcade dosage: 1.5 MG, INTRAVENOUS. During the same period patient was treated with NOVALGIN, TEMGESIC. Patient was hospitalized. Patient died on 09/14/2005.


Velcade Side Effects Report #5591256-0
Velcade side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma , pneumonia . Velcade dosage: unknown. During the same period patient was treated with REVLIMID, ZOMETA. Patient died on 06/02/2007.

Velcade Side Effects Report #5656259-6
Velcade side effect was reported by a Physician from UNITED KINGDOM on Feb 21, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.40 MG; 1.30 MG. Patient died on 01/31/2008.

Velcade Side Effects Report #6009121-3
Velcade side effect was reported by a Physician from JAPAN on Dec 04, 2008. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diplegia, dysstasia, leukoencephalopathy, malignant neoplasm progression, paresis, platelet count decreased, pyrexia. Velcade dosage: 1.70MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OXYCONTIN, ETODOLAC, RIZE, DOGMATYL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LENDORM, ZANTAC. Patient was hospitalized. Patient died on 03/18/2008.

Velcade Side Effects Report #4958274-4
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Mar 09, 2006. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac enzymes increased, diarrhoea, haematemesis, hypothermia , malignant neoplasm progression, multiple myeloma , neutropenia, rectal haemorrhage. Velcade dosage: 210 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE. Patient died.

Velcade Side Effects Report #5054141-9
Velcade side effect was reported by a Physician from ITALY on June 26, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to central nervous system, metastases to skin, multiple myeloma . Velcade dosage: 1.30 MG/M2. Patient died.


Velcade Side Effects Report #5115304-7
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 11, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomyopathy , fatigue, heart rate increased, infection , malignant neoplasm progression, mitral valve incompetence, multiple myeloma , ventricular hypokinesia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.

Velcade Side Effects Report #5129788-1
Velcade side effect was reported by a Physician from NETHERLANDS on Oct 04, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomyopathy , fatigue, infection , malignant neoplasm progression, mitral valve incompetence, multiple myeloma . Velcade dosage: 1.30 MG/M2 INTRAVENOUS. Patient died.

Velcade Side Effects Report #5746167-4
Velcade side effect was reported by a Physician from SWITZERLAND on May 06, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemolysis, haemolytic anaemia, infection , malignant neoplasm progression, multiple myeloma . Velcade dosage: 2 MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS. Patient died on 04/09/2008.

Velcade Side Effects Report #6128774-2
Velcade side effect was reported by a Physician from JAPAN on Mar 11, 2009. Male patient, 74 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coma hepatic, hyperammonaemia, hyperventilation, malignant neoplasm progression, metabolic acidosis, multiple myeloma , no therapeutic response, psychiatric symptom, respiratory failure. Velcade dosage: 2.1 MG INTRAVENOUS. During the same period patient was treated with LANSOPRAZOLE, METHYCOBAL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ITRACONAZOLE, FENTANYL. Patient died on 02/18/2009.

Velcade Side Effects Report #5268364-7
Velcade side effect was reported by a Physician from JAPAN on Mar 02, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, malignant neoplasm progression, multiple myeloma , oliguria, renal disorder, renal failure, respiratory failure. Velcade dosage: 2.30 MG, IV DRIP. Patient died on 12/08/2006.


Velcade Side Effects Report #5376668-2
Velcade side effect was reported by a Physician from SWITZERLAND on June 18, 2007. Male patient, 73 years of age, weighting 185.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: lymphoma , malignant neoplasm progression, thrombocytopenia. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient died on 02/10/2007.

Velcade Side Effects Report #5832233-1
Velcade side effect was reported by a Physician from JAPAN on July 24, 2008. Female patient, 73 years of age, weighting 131.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: unknown. Patient died on 07/24/2008.

Velcade Side Effects Report #5103999-3
Velcade side effect was reported by a Physician from GERMANY on Aug 31, 2006. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 05/27/2006.

Velcade Side Effects Report #6050693-0
Velcade side effect was reported by a Physician from JAPAN on Jan 09, 2009. Male patient, 71 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient died on 10/01/2008.

Velcade Side Effects Report #5455043-6
Velcade side effect was reported by a Physician from FRANCE on Sept 03, 2007. Female patient, 70 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, polyneuropathy, thrombocytopenia. Velcade dosage: 2.25 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LYRICA. Patient died on 02/05/2007.

Velcade Side Effects Report #5625233-8
Velcade side effect was reported by a Physician from JAPAN on Jan 30, 2008. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 01/10/2008.

Velcade Side Effects Report #5015873-1
Velcade side effect was reported by a Physician from CANADA on May 18, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died on 12/03/2005.

Velcade Side Effects Report #5023337-4
Velcade side effect was reported by a Physician from CANADA on May 26, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, fatigue, malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with EPREX, HYDROCHLOROTHIAZIDE, VITAMIN D, VASOFED, ASCORBIC ACID, PAMIDRONATE DI. Patient was hospitalized. Patient died on 12/03/2005.

Velcade Side Effects Report #5084876-3
Velcade side effect was reported by a Physician from GERMANY on Aug 03, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, plasmacytoma, pneumonia , pyrexia, stem cell transplant, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with BENDAMUSTINE, MELPHALAN, DEXAMETHASONE, LEVOFLOXACIN, PANTOZOL, ENOXAPARIN, VORICONAZOLE. Patient died on 02/13/2006.

Velcade Side Effects Report #5165720-2
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2006. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, infection , malignant neoplasm progression, multiple myeloma , thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient died on 09/14/2006.


Velcade Side Effects Report #5704586-6
Velcade side effect was reported by a Physician from UNITED STATES on Mar 31, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: unknown. Patient died on 08/30/2007.

Velcade Side Effects Report #5954886-X
Velcade side effect was reported by a Physician from SPAIN on Nov 05, 2008. Female patient, 69 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , subdural haemorrhage, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died on 10/01/2008.

Velcade Side Effects Report #5549729-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , transplant failure. Velcade dosage: unknown. During the same period patient was treated with REVLIMID, DECADRON. Patient died on 12/15/2006.

Velcade Side Effects Report #6024402-5
Velcade side effect was reported by a Physician from JAPAN on Dec 15, 2008. Male patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. Patient died on 11/01/2008.

Velcade Side Effects Report #5764264-4
Velcade side effect was reported by a Physician from UNITED STATES on May 27, 2008. Female patient, 67 years of age, weighting 153.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bone pain, cardiomegaly, hypercalcaemia, lethargy, malignant neoplasm progression, mental status changes, multiple myeloma . Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, DUONEB, MAGIC MOUTH WASH, FLUCONAZOLE, LIDOCAINE VISCOUS, ALLEGRA, ATIVAN, CARFATE. Patient was hospitalized. Patient died on 08/08/2007.

Velcade Side Effects Report #5984813-0
Velcade side effect was reported by a Physician from JAPAN on Nov 21, 2008. Male patient, 67 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: 1.9 MG,INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 09/01/2008.

Velcade Side Effects Report #6134286-2
Velcade side effect was reported by a Pharmacist from UNITED KINGDOM on Mar 09, 2009. Female patient, 67 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , spinal cord compression. Velcade dosage: 2.2 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 02/20/2009.

Velcade Side Effects Report #4700821-1
Velcade side effect was reported by a Health Professional from on June 27, 2005. Female patient, 67 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: difficult to wean from ventilator, hypertension, hypoxia, laboratory test abnormal, malignant neoplasm progression, multi-organ failure, multiple myeloma , pleural effusion, renal failure. Velcade dosage: 1.6 MG/M2 INJECTION. During the same period patient was treated with THALIDOMIDE, LEVOTHYROXINE, OXYCONTIN, OXYCODONE, ACYCLOVIR, LEVEFLOXACIN, FLUCONAZOLE, LASIX. Patient died on 04/26/2005.

Velcade Side Effects Report #4976246-0
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 03, 2006. Female patient, 67 years of age, weighting 137.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia , blood pressure decreased, dehydration, malignant neoplasm progression, multiple myeloma , nausea . Velcade dosage: 2.10 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with SPIRONOLACTONE, SOTALOL, FUROSEMIDE, PARACETAMOL, AMIODARONE. Patient died on 05/11/2005.

Velcade Side Effects Report #5020032-2
Velcade side effect was reported by a Physician from CANADA on May 23, 2006. Male patient, 67 years of age, weighting 249.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with MS CONTIN, CELEBREX, METFORMIN, GLYBURIDE, AMITRIPTYLINE, EPREX, RHOVANE, ACETAMINOPHEN. Patient died on 10/12/2004.


Velcade Side Effects Report #4976251-4
Velcade side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2006. Male patient, 66 years of age, weighting 163.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium increased, cardiac failure congestive, malignant neoplasm progression, monoclonal immunoglobulin present, multiple myeloma , pulmonary arterial pressure increased. Velcade dosage: unknown. During the same period patient was treated with ALLOPURINOL, GRANISETRON, DEXAMETHASONE, OMEPRAZOLE, PAMIDRONATE DI, RAMIPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 01/21/2006.

Velcade Side Effects Report #5281185-4
Velcade side effect was reported by a Physician from IRELAND on Mar 12, 2007. Female patient, 65 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, thrombocytopenia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE, AMLODIPINE, BISOPROLOL FUMARATE. Patient died on 02/10/2007.

Velcade Side Effects Report #5297885-6
Velcade side effect was reported by a Physician from JAPAN on Mar 27, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coma, convulsion, malignant neoplasm progression, platelet count decreased, renal impairment. Velcade dosage: 2.00 MG. During the same period patient was treated with PREDNISOLONE, BAKTAR, ALLOPURINOL, BLOPRESS, CALBLOCK, GLIMICRON, PRIMPERAN, RED BLOOD CELLS. Patient died on 03/25/2007.

Velcade Side Effects Report #5324055-5
Velcade side effect was reported by a Physician from FRANCE on Apr 25, 2007. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.40 MG, INTRAVENOUS. Patient died on 05/23/2006.

Velcade Side Effects Report #5724966-2
Velcade side effect was reported by a Physician from JAPAN on Apr 18, 2008. Female patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 04/07/2008.

Velcade Side Effects Report #6076292-2
Velcade side effect was reported by a Physician from JAPAN on Jan 28, 2009. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, blood lactate dehydrogenase increased, c-reactive protein increased, chest pain , disease progression, disorientation, laboratory test abnormal, malignant neoplasm progression, multiple myeloma . Velcade dosage: 2 MG/M2, INTRAVENOUS. During the same period patient was treated with ALGINATE, VOLTAREN, NIZATIDINE, MUCOSTA, URSO, LASIX, IDOMETHINE, XYLOCAINE. Patient died on 01/02/2009.

Velcade Side Effects Report #6094669-6
Velcade side effect was reported by a Pharmacist from UNITED KINGDOM on Feb 09, 2009. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant melanoma, malignant neoplasm progression, pneumonia , renal failure. Velcade dosage: 1.3 MG/M2,. During the same period patient was treated with ACYCLOVIR, DAPSONE, DEXAMETHASONE, CLODRONATE DI. Patient died.

Velcade Side Effects Report #4699745-8
Velcade side effect was reported by a Physician from on June 08, 2005. Female patient, 65 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , renal failure, rhabdomyolysis. Velcade dosage: 2.30 MG, 2/WEEKS, IV BOLUS. During the same period patient was treated with ALLOPURINOL, UNIPRIL, NEORECORMON, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4806910-5
Velcade side effect was reported by a Physician from HUNGARY on Oct 04, 2005. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: coagulopathy, dialysis , diarrhoea, hypercalcaemia, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma , plasmacytosis, polyuria. Velcade dosage: 2.30 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 09/28/2005.

Velcade Side Effects Report #4995822-2
Velcade side effect was reported by a Physician from GERMANY on Apr 24, 2006. Female patient, 65 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: infection , malignant neoplasm progression, multiple myeloma , pyrexia. Velcade dosage: 2.40 MG, UNK, INTRAVENOUS. Patient was hospitalized. Patient died on 04/09/2005.


Velcade Side Effects Report #4708809-1
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 20, 2005. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: lower respiratory tract infection, malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.3 MG BIW, IV BOLUS. During the same period patient was treated with ALLOPURINOL, RANITIDINE, GAVISCON, SOLPADOL, PAMIDRONATE DI, ORAMORPH, DICLOFENAC, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 02/19/2003.

Velcade Side Effects Report #5304689-4
Velcade side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Apr 04, 2007. Female patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with NEURONTIN, AMITRIPTYLINE, APPROVEL, GLUCOBAY, NATEGLINIDE. Patient died on 01/16/2007.

Velcade Side Effects Report #5332904-X
Velcade side effect was reported by a Pharmacist from AUSTRALIA on May 09, 2007. Male patient, 63 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , no therapeutic response. Velcade dosage: 2.30 MG,. Patient died on 05/01/2007.

Velcade Side Effects Report #5976519-9
Velcade side effect was reported by a Physician from JAPAN on Nov 13, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , diarrhoea, malignant neoplasm progression, neurogenic bladder, neuropathy peripheral. Velcade dosage: unknown. During the same period patient was treated with DEXANETHASONE. Patient recovered.

Velcade Side Effects Report #5990218-9
Velcade side effect was reported by a Physician from THAILAND on Nov 24, 2008. Male patient, 63 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: endocarditis , malignant neoplasm progression, staphylococcal infection , thrombophlebitis. Velcade dosage: 1.90 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4815913-6
Velcade side effect was reported by a Physician from POLAND on Oct 13, 2005. Female patient, 63 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemodynamic instability, infection in an immunocompromised host, malignant neoplasm progression, multiple myeloma , urosepsis. Velcade dosage: 1.00 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DURAGESIC, CYCLONAMINE, MILURIT, AREDIA, FUROSEMIDE, RANIGAST. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4946420-8
Velcade side effect was reported by a Physician from UNITED STATES on Feb 24, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chills, ear pain, febrile neutropenia, malignant neoplasm progression, oedema peripheral, otorrhoea, oxygen saturation decreased, platelet count decreased, pneumonia . Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, ALLEGRA, VITAMINS, PRAVACHOL, QUININE, COLACE, SENOKOT, SPIRIVA. Patient was hospitalized. Patient died on 11/24/2005.

Velcade Side Effects Report #5030939-8
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 08, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , spinal cord compression. Velcade dosage: unknown. Patient died on 05/24/2006.

Velcade Side Effects Report #5255425-1
Velcade side effect was reported by a Physician from JAPAN on Feb 21, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , pulmonary oedema, renal impairment. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DECADRON. Patient died on 02/02/2007.

Velcade Side Effects Report #5268766-9
Velcade side effect was reported by a Physician from JAPAN on Feb 28, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , pulmonary oedema, renal impairment. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DECADRON. Patient died on 02/02/2007.


Velcade Side Effects Report #5336422-4
Velcade side effect was reported by a Physician from JAPAN on May 10, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, malignant neoplasm progression, multiple myeloma , myelodysplastic syndrome, nausea , pulmonary oedema, respiratory failure, thrombocytopenia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, AMOBAN, CARBAMAZEPINE, LOXONIN, NOVAMIN, OXYCONTIN, PURSENNID. Patient died on 02/02/2007.

Velcade Side Effects Report #5400638-9
Velcade side effect was reported by a Physician from JAPAN on July 11, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, depression , malignant neoplasm progression, multiple myeloma , pneumonia , pulmonary oedema. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with DEXAMETHASONE, AMOBAN, CARBAMAZEPINE, LOXONIN, NOVAMIN, OXYCONTIN, PURSENNID. Patient died on 02/02/2007.

Velcade Side Effects Report #5615489-X
Velcade side effect was reported by a Physician from IRELAND on Jan 21, 2008. Male patient, 62 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , autonomic neuropathy, constipation , diarrhoea, malignant neoplasm progression, multi-organ failure, multiple myeloma , nervous system disorder, respiratory failure. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOPRAZOLE. Patient was hospitalized. Patient died on 11/28/2007.

Velcade Side Effects Report #5729656-8
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 21, 2008. Male patient, 62 years of age, weighting 205.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , thrombocytopenia. Velcade dosage: 2.80 MG; 2.20 MG. During the same period patient was treated with DEXAMETHASONE, METFORMIN, GLYBURIDE. Patient died.

Velcade Side Effects Report #4737828-4
Velcade side effect was reported by a Physician from NETHERLANDS on July 21, 2005. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: emphysema, leukocytoclastic vasculitis, malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, 2/WEEK; IV BOLUS. During the same period patient was treated with PREDNISONE. Patient recovered.

Velcade Side Effects Report #5242775-8
Velcade side effect was reported by a Pharmacist from AUSTRALIA on Feb 01, 2007. Male patient, 61 years of age, weighting 220.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone marrow failure, malignant neoplasm progression, multiple myeloma , pancytopenia. Velcade dosage: 2.50 MG. Patient died on 01/08/2007.

Velcade Side Effects Report #5261536-7
Velcade side effect was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hepatic function abnormal, malignant neoplasm progression, multiple myeloma , peripheral sensory neuropathy, platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 02/18/2007.

Velcade Side Effects Report #5302474-0
Velcade side effect was reported by a Physician from JAPAN on Mar 30, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood lactate dehydrogenase increased, hepatic function abnormal, herpes zoster, ileus paralytic, malignant neoplasm progression, peripheral sensory neuropathy, platelet count decreased. Velcade dosage: 1.60 MG , INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 02/18/2007.

Velcade Side Effects Report #5306514-4
Velcade side effect was reported by a Physician from JAPAN on Apr 06, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood lactate dehydrogenase increased, herpes zoster, ileus paralytic, malignant neoplasm progression. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 02/18/2007.

Velcade Side Effects Report #5371208-6
Velcade side effect was reported by a Pharmacist from UNITED KINGDOM on June 11, 2007. Female patient, 61 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac disorder, cerebrovascular disorder, disease progression, lower respiratory tract infection, malignant neoplasm progression, myocardial infarction, pulmonary oedema, renal impairment, septic shock. Velcade dosage: unknown. During the same period patient was treated with BICARBONATE IN PLASTIC CONTAINER, CALCICHEW, LANSOPRAZOLE, DOMPERIDONE, ALLOPURINOL, POTASSIUM CHLORIDE, METRONIDAZOLE, PHOSPHATE. Patient died on 02/28/2007.

Velcade Side Effects Report #5385367-2
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on June 27, 2007. Male patient, 61 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, STILLEN. Patient died on 03/08/2007.

Velcade Side Effects Report #5391778-1
Velcade side effect was reported by a Physician from PHILIPPINES on July 06, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2. Patient died on 06/01/2007.

Velcade Side Effects Report #5976540-0
Velcade side effect was reported by a Physician from JAPAN on Nov 14, 2008. Male patient, 61 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, bronchioloalveolar carcinoma, constipation , herpes zoster disseminated, ileus paralytic, infection , lung infiltration malignant, malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.1 MG, INTRAVENOUS, 1.6 MG, IV. During the same period patient was treated with MUCOSTA, ITRACONAZOLE, FAMOTIDINE, BIO THREE, ACETAMINOPHEN, LOXOPROFEN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4765646-X
Velcade side effect was reported by a Physician from SWITZERLAND on Aug 22, 2005. Male patient, 61 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, c-reactive protein increased, dyspnoea, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma . Velcade dosage: 2.30 MG/M2, SINGLE. Patient was hospitalized. Patient died on 04/09/2005.

Velcade Side Effects Report #4866838-1
Velcade side effect was reported by a Physician from UNITED KINGDOM on Dec 07, 2005. Female patient, 61 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, DOTHIEPIN HYDROCHLORIDE, BENDROFLUAZIDE, CANDESARTAN, GLYBURIDE, PANTOPRAZOLE, BISOPROLOL, ASPIRIN. Patient died on 03/28/2005.

Velcade Side Effects Report #5851876-2
Velcade side effect was reported by a Physician from JAPAN on Aug 07, 2008. Female patient, 60 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, multiple myeloma , varicella. Velcade dosage: 2 MG, UNK, INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, ALLOPURINOL, MUCOSTA. Patient died.

Velcade Side Effects Report #5901804-6
Velcade side effect was reported by a Health Professional from COLOMBIA on Sept 17, 2008. Female patient, 60 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastasis, multiple myeloma , plasmacytoma. Velcade dosage: 1.2 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #6111468-7
Velcade side effect was reported by a Physician from GREECE on Feb 24, 2009. Female patient, 60 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , pneumocystis jiroveci pneumonia. Velcade dosage: 1 MG/M2, IV BOLUS. During the same period patient was treated with MELPHALAN, THALIDOMIDE, DEXAMETHASONE, VALACYCLOVIR, ZOLEDRONIC ACID. Patient died on 11/17/2008.

Velcade Side Effects Report #5518682-X
Velcade side effect was reported by a Physician from ITALY on Nov 01, 2007. Female patient, 59 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, leukocytoclastic vasculitis, malignant neoplasm progression, multiple myeloma , nausea , stem cell transplant, tumour lysis syndrome, vasculitis gastrointestinal. Velcade dosage: 1.30 MG/M2 ; 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5067534-0
Velcade side effect was reported by a Physician from AUSTRALIA on July 17, 2006. Male patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Velcade dosage: unknown. Patient died on 02/28/2006.

Velcade Side Effects Report #5002655-X
Velcade side effect was reported by a Physician from JAPAN on Apr 05, 2006. Female patient, 58 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: leukaemia, malignant neoplasm progression, multiple myeloma , pyrexia. Velcade dosage: unknown. During the same period patient was treated with INTERFERON. Patient died on 02/20/2006.